Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Central Institute of Mental Health, Mannheim
With
University of Cologne
Age
18–45
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Informed consent given by the subject
Both, female and male subjects may participate
Age between 18 and 45
Negative drug screening at the time of screening
Non-smoking
In female participants in fertile age, reliable contraception, which means contraception's pearl-index is equal or smaller than 1.
Body Mass Index between 18 and 30
You may not be if
Lack of accountability
Any current psychiatric disorder through the Structured Clinical Interview for DSM-IV (SCID) at the time of screening
Pregnancy or lactation phase in female at the time of screening
Any known psychiatric or neurological illness in the participant's history.
Known family history concerning psychiatric disorders
Relevant use of cannabis (which is defined on the present state of knowledge as at the most five times lifetime-consumption and no consumption for at least one year)
Severe physical (internal) or neurological illness, especially cardiovascular, renal, advanced respiratory, haematological or endocrinological failures or infectious diseases (acute hepatitis A, B or C or HIV) assessed at the time of the screening by the subject's history, clinical examination and laboratory testing, at the discretion of the investigator
Consumption of any illicit drugs (except cannabis in history, see above)
Clareo Health | Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study
